Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 12—December 2024
Dispatch
Mpox Vaccine Acceptance, Democratic Republic of the Congo
Skylar Petrichko1, Jason Kindrachuk1, Dalau Nkamba, Megan Halbrook, Sydney Merritt, Handdy Kalengi, Leonard Kamba, Michael Beya, Nicole A. Hoff, Christophe Luhata, Didine K. Kaba2, and Anne W. Rimoin2
Table
Characteristics of participants in a telephone phone survey about mpox vaccine acceptance conducted during December 2023–February 2024, Democratic Republic of the Congo*
| Characteristics | Value, n = 5,226 |
|---|---|
| Median age (IQR) |
42 (26–58) |
| Sex | |
| M | 4,138 (79.2) |
| F |
1,088 (20.8) |
| Education level | |
| Less than high school | 359 (6.9) |
| Graduated high school | 1,589 (30.4) |
| Some college | 2,158 (41.3) |
| Bachelor or advanced degree |
1,120 (21.4) |
| Province | |
| Maindombe | 134 (2.6) |
| Kwango | 183 (3.5) |
| Kwilu | 657 (12.6) |
| Kongo Central | 312 (6.0) |
| Equateur | 162 (3.1) |
| Mongala | 238 (4.6) |
| Tshuapa | 63 (1.2) |
| Nord Ubangi | 113 (2.2) |
| Sud Ubangi | 91 (1.7) |
| Kasai Oriental | 597 (11.4) |
| Sankuru | 176 (3.4) |
| Lomami | 192 (3.7) |
| Kasai | 118 (2.3) |
| Kasai Central | 87 (1.7) |
| Haut Katanga | 331 (6.3) |
| Tanganyika | 151 (2.9) |
| Haut Lomami | 50 (1.0) |
| Lualaba | 168 (3.2) |
| Kinshasa | 251 (4.8) |
| Maniema | 98 (1.9) |
| North Kivu | 140 (2.7) |
| Bas Uele | 246 (4.7) |
| Haut Uele | 137 (2.6) |
| Ituri | 239 (4.6) |
| Tshopo | 144 (2.8) |
| Sud Kivu |
148 (2.8) |
| Geographic area | |
| Urban | 2,659 (50.9) |
| Rural |
2,567 (49.1) |
| Occupation | |
| Healthcare worker | 2,899 (55.5) |
| Religious leader | 89 (1.7) |
| Community or essential services leader | 768 (14.7) |
| Public service sector or educator | 670 (12.8) |
| Other worker | 513 (9.8) |
| Not working |
287 (5.5) |
| Health conditions | |
| Chronic lung disease | 32 (0.6) |
| Diabetes | 209 (4.0) |
| Cardiovascular disease | 254 (4.9) |
| Chronic renal disease | 12 (0.2) |
| Chronic liver disease | 9 (0.2) |
| Immunocompromised | 10 (0.2) |
| No conditions | 4,700 (89.9) |
*Values are no. (%) except as indicated. IQR, interquartile range.
1These first authors contributed equally to this article.
2These last authors contributed equally to this article.
Page created: October 15, 2024
Page updated: October 23, 2024
Page reviewed: October 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.